What Prostate Cancer UK does

Prostate Cancer UK is a registered charity (England and Wales number 1005541, Scotland number SC039332) founded in 1996 and headquartered in London, operating as the largest men's health charity in the UK and the only major UK charity dedicated solely to prostate cancer. Its mission centres on improving survival and quality of life for men with prostate cancer through three integrated activities: funding large-scale research, delivering direct support services to patients and families, and campaigning for improved NHS care and earlier diagnosis.

The organisation funds a substantial research portfolio, most notably the £42 million TRANSFORM trial (up to 300,000 men) developed with the Institute of Cancer Research and backed by an additional £18 million UK Government investment, plus the £1.9 million Vanguard Path study with the University of Oxford testing the ArteraAI Prostate Biopsy Assay across three NHS sites. Direct services include a Specialist Nurse Support Line (0800 074 8383), an online Risk Checker, moderated online community forums, one-to-one peer support (including a dedicated Black Men's service), specialist-nurse-led webinars, and the Exercise as Medicine and Wellbeing Hubs. Healthcare-professional offerings include Clinical Champions training, an Active Surveillance Hub, and a Consultation Toolkit, while the Patient Representative Network embeds lived experience into research funding decisions.

The revenue model is diversified across one-time and monthly recurring donations, nationwide fundraising events (March for Men, Ultra Challenges across 20 UK locations, The Big Golf Race, Royal Parks Half Marathon), corporate partnerships (including The Even Bigger 180 programme), licensing and merchandise processed through wholly-owned subsidiary Prostate Cancer Trading Ltd, legacies, and trust and foundation grants (notably The Movember Foundation). Pricing is donation-based with suggested tiers (£20/£50/£100 one-off, £10/£15/£25 monthly) and a £2 minimum, while all support services are free at point of use. Geographic scope is UK-only.

Name

Prostate Cancer UK

Legal name

Prostate Cancer UK

Website

https://prostatecanceruk.org

Company type

Private

Founded year

1996

Operating status

Operating

Headcount range

101–250 employees

Short description

Prostate Cancer UK is the UK's largest men's health charity, funding prostate cancer research (including the £42M TRANSFORM trial), providing specialist nurse and peer support services, and campaigning for earlier diagnosis and improved NHS care.

Ownership category

akta.pro rank

Product category

Health charity services

NAICS

Voluntary Health Organizations (813212), Grantmaking and Giving Services (8132), Grantmaking Foundations (813211), Social Advocacy Organizations (81331)

SIC

Services-Social Services (8300), Services-Health Services (8000)

akta.pro primary industry

Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS) (BPAGACAA)

akta.pro secondary industry

Health & Medical Research Grantmaking Foundations (BPAGAKAL)

Keywords

• Prostate cancer research
• Cancer support services
• Men's health charity
• Specialist nurse support
• Cancer fundraising events

Headquarters

HQ city

London

HQ country

United Kingdom

HQ region

Europe

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Marketing or Sales, Operations, Technology or R&D, Infrastructure, Others

Revenue model

1. Donations: One-time and recurring donations from individual supporters, with options for monthly giving. Minimum donation of £2 due to processing costs.
2. Fundraising Events: Revenue from organized events including running events, golf tournaments, cycling challenges, walking events, and ultra challenges across the UK.
3. Corporate Partnerships: Charity partnerships with companies through The Even Bigger 180 programme and other partnership opportunities, including licensing income from partnerships processed through Prostate Cancer Trading Ltd.
4. Online Shop Sales: Sales of merchandise including Man of Men pin badges through Prostate Cancer Trading Ltd subsidiary.
5. Legacies and Wills: Gifts left in supporters' wills to fund future research and support services.
6. Philanthropy and Trusts: Funding from charitable trusts and foundations, including major partnerships such as with The Movember Foundation.

Pricing tiers

Go-to-market motion3 records

Distribution channels6 records

Marketing channels10 records

Core offering

Prostate Cancer UK is the UK's largest charity dedicated to prostate cancer, providing free information, specialist nurse support, and peer-support services to men affected by the disease, alongside funding large-scale research programmes such as the £42 million TRANSFORM screening trial. It runs nationwide fundraising events (March for Men, golf, running, cycling and ultra challenges), accepts individual and corporate donations, and operates the Man of Men brand to drive awareness, risk checking, and policy campaigns for improved NHS treatment access.

Product overview

Prostate Cancer UK operates a comprehensive digital support ecosystem centered on its primary website, offering information resources, risk assessment tools, and direct support services. The organization provides a risk checker tool for men to assess their prostate cancer risk, alongside Specialist Nurses accessible via phone, email, and online chat. The organization hosts an Online Community for peer support and maintains a Patient Representative Network where volunteers with lived experience help shape research priorities. Major initiatives include the landmark £42 million TRANSFORM trial for prostate cancer screening. Additional services encompass educational webinars, publications, wellbeing resources, and training programmes for healthcare professionals including the Clinical Champions Programme and Consultation Toolkit.

Differentiator

Problem solved

Functional benefit

Products and services

• Specialist Nurse Support Service Free, confidential telephone, email, and online chat support from specialist nurses for men and families concerned about prostate cancer or prostate problems.
• Risk Checker An online tool that allows men to assess their prostate cancer risk in 30 seconds by answering three quick questions about age, ethnicity, and family history. Targeted at men over 50, Black men, and those with family history.
• Online Community A moderated online forum where men and families affected by prostate cancer share information and support each other through personal experiences.
• One-to-One Peer Support Service Personalised one-on-one support matching individuals with trained volunteers who have lived experience of prostate cancer.
• Black Men's One-to-One Support Service A specialised peer support service designed for Black men, addressing their elevated risk (1 in 4) of prostate cancer.
• Specialist Nurse-led Webinars Online educational sessions led by specialist nurses covering various aspects of prostate cancer diagnosis, treatment, and living with the condition.
• Patient Representative Network A volunteer network of men and family members affected by prostate cancer who help shape research by providing feedback to researchers.
• Clinical Champions Programme A training programme for healthcare professionals to improve prostate cancer care standards, including active surveillance, consultation, and innovation.
• Health and Social Care Professionals Programme A Movember Foundation-supported programme funding NHS health professionals to test new or innovative models of care for men living with and beyond prostate cancer; has funded 59 health professionals to date.
• TRANSFORM Trial A landmark £42 million UK prostate cancer screening study (the largest in over 20 years), involving up to 300,000 men, evaluating PSA blood tests, genetic saliva analysis, and MRI scans. Co-funded with an £18 million UK Government investment.
• Vanguard Path Study A £1.9 million, three-year study led by the University of Oxford testing the ArteraAI Prostate Biopsy Assay AI tool across three NHS sites, involving biopsies from over 4,000 men.
• March for Men Annual nationwide sponsored walking fundraising events held in June to raise money and awareness for prostate cancer.
• The Big Golf Race A charity golf fundraising event for supporters to raise money for Prostate Cancer UK.
• Ultra Challenges Multi-distance fundraising challenges (100km, 50km, 75km, 25km, 10km or Marathon) across 20 UK locations.
• Royal Parks Half Marathon Charity running event participation in the Royal Parks Half Marathon as a fundraising activity.
• Prostate Cancer UK Online Shop Online merchandise shop operated via Prostate Cancer Trading Ltd, selling items including Man of Men pin badges and other charity merchandise.
• Wellbeing Hub Resources and support service providing information to improve wellbeing during and after prostate cancer treatment.
• Publications Library Free downloadable and printable information materials covering prostate cancer risk, diagnosis, treatment options, and living with the disease.
• Exercise as Medicine Hub Resource hub and evidence review on exercise as a therapeutic intervention for men with prostate cancer, including a directory to find local exercise groups.
• Active Surveillance Hub Guidelines and resources for healthcare professionals managing patients on active surveillance for prostate cancer.
• Consultation Toolkit Resources for healthcare professionals to support patients being referred for suspected prostate cancer.
• Prostate Health Hub (newsletter) Email newsletter providing articles with specialist insights, practical tips for living well, and personal stories for those affected by prostate cancer.
• The Even Bigger 180 Corporate Partnership Programme Corporate charity partnership programme for UK companies, including licensing and partnership opportunities processed through wholly-owned subsidiary Prostate Cancer Trading Ltd.
• MOBO Awards 2026 Partnership A partnership with the MOBO Awards 2026 ceremony celebrating 'MOBO Salutes: Grime 25' and MOBO's 30th milestone, raising awareness and funds for prostate cancer among diverse audiences.

Quantifiable outcome

• Transformed prostate cancer diagnosis through multiparametric MRI adoption across NHS
• +7 more outcomes

Named customers6 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Seven partnerships are on record, tiered core and minor.

• MOBO AwardscoreStrategic or Co-development Partner · 1 March 2026Prostate Cancer UK partnered with MOBO Awards for the 2026 ceremony celebrating 'MOBO Salutes: Grime 25' marking the genre's 25th anniversary alongside MOBO's own 30th milestone. The partnership includes additional performers (Wiley, Chip, DJ Target, Nolay, Scorcher, D Double E) with the event hosted by Eve and Eddie Kadi at Manchester's Co-op Live. This partnership supports awareness and fundraising for prostate cancer among diverse audiences.
• University of OxfordcoreStrategic or Co-development Partner · 1 November 2025University of Oxford researchers lead the £1.9 million Vanguard Path study funded by Prostate Cancer UK to test the ArteraAI Prostate Biopsy Assay AI tool in NHS hospitals. The three-year study involves biopsies from over 4,000 men across three NHS sites.
• Institute of Cancer Research, LondoncoreStrategic or Co-development Partner · 1 November 2025The Institute of Cancer Research, London has launched the £42 million TRANSFORM trial, the UK's largest prostate cancer screening study in over 20 years, involving up to 300,000 men. The trial aims to improve early detection and address inequalities affecting Black men.
• NHS EnglandcoreImplementation/ SI/ Consulting Partner · 1 November 2025NHS England is rolling out Stereotactic Ablative Radiotherapy (SABR) for prostate cancer treatment across all 48 NHS radiotherapy centres, reducing treatment sessions from 20 to just 5 for approximately 3,500 patients annually.
• The Movember FoundationcoreStrategic or Co-development PartnerThe Movember Foundation has provided support for the Health and Social Care Professionals Programme, funding 59 health professionals in the NHS to test new or innovative models of care to support men living with and beyond prostate cancer. This partnership has enabled projects like the Belfast Health and Social Care Trust specialist physiotherapy continence service.
• Amazon MusicminorGTM or Marketing PartnerAmazon Music is listed as a partner for MOBO Awards 2026 alongside Prostate Cancer UK, providing promotional and marketing support for the joint initiative.
• PPL (Phonographic Performance Limited)minorGTM or Marketing PartnerPPL supported the MOBO Fringe: Manchester Talent Programme as part of the 2025 Newcastle programme that generated £1 million+ economic impact, continuing support for 2026 MOBO partnership.

Scale indicators14 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• British Heart Foundation: The British Heart Foundation is one of the UK's largest health charities and a close comparator in scale, multi-channel fundraising (charity shops, events, donations), and research funding model — useful for benchmarking operational and fundraising scale.
• Macmillan Cancer Support: Macmillan is one of the largest UK cancer charities, providing nurse support, information, and financial assistance to people affected by all cancer types. It overlaps directly with Prostate Cancer UK's specialist nurse support and information services but serves a broader cancer population.
• Cancer Research UK: Cancer Research UK is the UK's largest cancer charity, funding research across all cancer types including prostate cancer. It competes with Prostate Cancer UK for donor mindshare and research commissioning influence but operates at a much larger scale across the full cancer landscape.

Direct peers

• Bowel Cancer UK: Bowel Cancer UK is a UK single-disease cancer charity funding research and providing support services — directly comparable in mission, supporter base, NHS engagement, and event-driven fundraising approach.
• Prostate Cancer Foundation (US): The Prostate Cancer Foundation is the largest US philanthropic funder of prostate cancer research, comparable to Prostate Cancer UK's research-funding arm but with a US geographic focus and higher research grant volumes.
• Breast Cancer Now: Breast Cancer Now is a UK single-disease cancer charity providing research funding, support services, and policy campaigning — structurally and operationally comparable to Prostate Cancer UK across the disease-specific charity model, GTM, and NHS partnership approach.
• ZERO Prostate Cancer: ZERO Prostate Cancer is the leading US prostate cancer charity, providing research funding, patient support, and advocacy. It is the closest international counterpart to Prostate Cancer UK in terms of mission, services offered, and advocacy focus.
• Pancreatic Cancer UK: Pancreatic Cancer UK is a UK single-disease cancer charity focused on research, support, and campaigning — comparable in organisational size, donor base, and operating model, offering a useful benchmark for a smaller, single-disease UK health charity.
• Movember Foundation: The Movember Foundation is a global men's health charity that funds prostate cancer research and support — directly comparable in mission, fundraising model (mass-participation events), and target donor base. It is also an active partner of Prostate Cancer UK via the Health and Social Care Professionals Programme.

Others

• Anthony Nolan: Anthony Nolan is a UK charity that operates a stem cell donor registry and funds blood cancer research — comparable as a UK-registered health charity with research-funding, supporter-engagement, and NHS partnership models, though addressing a different disease area.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/ProstateUK
• YouTubeyoutube.com/tpccuk
• Facebookfacebook.com/prostatecanceruk
• Instagraminstagram.com/prostatecanceruk

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Prostate Cancer UK